IFNAR1 and acute respiratory distress syndrome: In our previous study, where we treated HS mice with anti-IFNAR1 antibody to block type I IFN recognition, we found beneficial outcomes in reducing inflammation, ALI, and survival, suggesting the detrimental role of type I IFN in HS (32).